Medical use and combination drug therapy among US adult users of central nervous system stimulants: a cross-sectional analysis.

ABSTRACT:

Objective

Examine patterns of adult medical use of amphetamine and methylphenidate stimulant drugs, classified in the USA as Schedule II controlled substances with a high potential for psychological or physical dependence.

Design

Cross-sectional study.

Setting and participants

Prescription drug claims for US adults, age 19-64 years, included in a commercial insurance claims database with 9.1 million continuously enrolled adults from 1 October 2019, through 31 December 2020. Stimulant use was defined as adults filling one or more stimulant prescriptions during calendar 2020.

Outcome measures

The primary outcome was an outpatient prescription claim, service date and days' supply for central nervous system (CNS)-active drugs. Combination-2 was defined as 60 days o

SUBMITTER: Moore TJ 

PROVIDER: S-EPMC10186433 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature